When antiretroviral therapy is working effectively, HIV cannot be transmitted. This allows people with HIV to live fuller lives without the fear of infecting others.
Cryptococcal ceningitis is one of the main causes of death of people with HIV. The tests and medicines to diagnose and treat it exist but remain inaccessible to most. A global strategy is needed.
Doctors Without Borders supporters march in protest to the American Consulate in Johannesburg in 2012 over lack of funding to fight HIV.
Photo by Foto24/Gallo Images/Getty Images
Hilton Humphries, Centre for the AIDS Program of Research in South Africa (CAPRISA)
Communities continue to be vital in efforts to bring the pandemic under control. They are the custodians of rich knowledge that creates the context in which HIV transmission occurs.
The drug is set to improve HIV treatment.
shutterstock
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all.
International AIDS Society/Rogan Ward
Current epidemiological and financial trends suggest there’s a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.
The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa.
Epa/Maurizio Gambarini
Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town